Sitting Down With George Calin, Professor, The University of Texas MD Anderson Cancer Center, USA.
Analyzing our 'second genome' could be the key to improving healthcare
Advanced mass spectrometry uncovers a tiny protein with important implications
Dipak Kalra, Iain Buchan, and Norman Paton
Big data. Everyone’s talking about it, but what exactly is it? And how can we best harness it?
Is the overwhelming focus on genomics and transcriptomics in translational science really the best way to help patients?
Advances in mass spectrometry and separation science are bringing genome-scale proteomic analyses within our reach.
To select the right treatment for each cancer patient, we need fast, accurate and cost-effective ways to characterize tumors. Now, with newly developed algorithms and protocols, mate pair sequencing could well be the tool we’ve been seeking.
We’ve come a long, long way already. Where next for NGS?
Shotgun sequencing is a powerful tool in microbial genomics, but viral genomes have proven tough to crack.
Sitting Down With…John Doench, Associate Director, Genetic Perturbation Platform, Broad Institute, Cambridge, MA, USA.
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.